Explore this weekend's OTT releases across Malayalam, Tamil, and Telugu. Thrillers, action, and dramas, including Kishkindha ...

MELD’s market cap is at $2.3 million. Revuto (REVU) is up 27.9% today and shows the potential for a skyrocketing week. Last ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

Syndax Pharmaceuticals (SNDX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kelly ...

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Syndax Pharmaceuticals (SNDX – Research Report). The associated ...

Revuforj is approved for relapsed or refractory acute leukemia with KMT2A translocation in patients aged 1 year and older. The AUGMENT-101 trial showed a 21.2% complete remission rate with a median ...

Syndax Pharmaceuticals won the first FDA approval last week in a new class of medicines called menin inhibitors. The treatment, Rejuforj, will be available as soon as this month for patients with an ...

A special CBI court granted bail to four CGST officers in a ₹50 lakh bribery case, marking the release of all accused involved.

The streaming platforms are gearing up for a big week with several highly anticipated releases. Here are the must-watch ...

A CBI court acquitted Jayant Mule and Santosh Bhosale of murder charges in the 2005 killing of businessman Sanjay Gupta, citing insufficient evidence.